| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. | Cancer Res | 2010 | 2.13 |
| 2 | Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression. | Diabetes | 2009 | 1.28 |
| 3 | Type 2 diabetes and cancer: what is the connection? | Mt Sinai J Med | 2010 | 1.16 |
| 4 | Growth hormone receptor regulates β cell hyperplasia and glucose-stimulated insulin secretion in obese mice. | J Clin Invest | 2011 | 1.12 |
| 5 | Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes. | Endocr Relat Cancer | 2010 | 0.98 |
| 6 | The GH/IGF-1 axis in growth and development: new insights derived from animal models. | Adv Pediatr | 2010 | 0.81 |